focus -WSS

focus

author：explore 2025-09-10 16:45:42 - browse：513

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Would Medicare drug price negotiations stall in a shutdown?

WSS

First transplant of an entire human eye performed

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Sudafed saga points to U.S. issues with evaluating older drugs

Listen: Who gets the credit for GLP

Intercept Pharmaceuticals sells itself for less than $1 billion

Today's health inequities arise from racist U.S. history, say experts

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Peter Hotez and the public health issue of online harassment

Why do women spend more than men on medical expenses?

ChatGPT in medicine: STAT answers readers' burning questions

Kaiser Permanente unions announce official strike date

At least 13 dead in Texas as scorching temps continue

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Moonlake's readout produced a cash windfall. Risks remain

Ionis has late

Jerome Adams on the need for new antivirals for Covid

Weight loss drugs should be covered by insurers, AMA says

hotspot

Did you have Obamacare on your GOP debate bingo card?

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Inequities make cancer less preventable for women: report

How the Dana

Covid vaccines: Private market messier than government rollout

Type 2 diabetes prevention programs work at large scale: study

explore

entertainment

leisure time

leisure time